Hennion & Walsh Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,423
| Closed | -$1.84M | – | 947 |
|
|
2025
Q1 | $1.84M | Sell |
62,423
-14,387
| -19% | -$425K | 0.08% | 293 |
|
|
2024
Q4 | $2.23M | Sell |
76,810
-1,428
| -2% | -$41.5K | 0.1% | 259 |
|
|
2024
Q3 | $3.59M | Sell |
78,238
-975
| -1% | -$44.8K | 0.17% | 151 |
|
|
2024
Q2 | $3.24M | Buy |
79,213
+6,241
| +9% | +$255K | 0.17% | 150 |
|
|
2024
Q1 | $1.86M | Buy |
72,972
+1,777
| +2% | +$45.3K | 0.1% | 269 |
|
|
2023
Q4 | $644K | Buy |
71,195
+4,975
| +8% | +$45K | 0.04% | 507 |
|
|
2023
Q3 | $422K | Buy |
66,220
+31,277
| +90% | +$200K | 0.03% | 563 |
|
|
2023
Q2 | $388K | Buy |
+34,943
| New | +$388K | 0.02% | 588 |
|